Abdominal organ related diseases
Conditions
Interventions
Group 1:Sufentanil 4-6ug/kg
Group 2:Sufentanil 2-3ug/kg
Group 3:Sufentanil 0.15-0.3ug/kg
Sponsors
Department of Anesthesiology, Xiangya Hospital, Central South University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. ASA I-III adult patients aged 18-65 years old; 2. Patients undergoing elective abdominal surgery; 3. Patients volunteered to participate in the trial and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Combined with severe cardiopulmonary disease, severe liver and kidney dysfunction (Child-Pugh B, C, CKD3-5) and neurological diseases or mental state abnormalities; 2. Combined with endocrine system and metabolic system diseases; 3. Tobacco and tobacco Or abuse of sedative, analgesic drugs, drinking coffee or tea-related liquid within 48 hours before surgery; 4. Allergic drugs. 5. Reluctant to participate in this study for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Pressure;Heart Rate;Bispectral index;Pulse oxygen saturation;Airway Pressure;Body Movement;Sweating;Tearing;Self-breathing;TOF;ß-endorphin;Blood Glucose;Norepinephrine;Cortisol;Numerical Rating Scale;Observer's assessment of alertness/sedation(OAA/S) scale; | — |
Countries
China
Contacts
Public ContactHW Cai
Department of Anesthesiology, Xiangya Hospital
Outcome results
None listed